PHYSICAL FORM OF A SGR MODULATOR

A crystalline form of 2,2-difluoro-N-[(1R,2S)-3-methyl-1-{[1-(1- methyl-6-oxo-1,6- dihydropyridin-3-yl)-1H-indazol-5-yl]oxy}-1-phenylbutan- 2-yl]propanamide (form C), pharmaceutical compositions containing it and its use in therapy. Una forma cristalina de 2,2-difluoro-N-[(1R,2S)-3-metil-1-{[1-(1-m...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	Deng CHAOYI
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A crystalline form of 2,2-difluoro-N-[(1R,2S)-3-methyl-1-{[1-(1- methyl-6-oxo-1,6- dihydropyridin-3-yl)-1H-indazol-5-yl]oxy}-1-phenylbutan- 2-yl]propanamide (form C), pharmaceutical compositions containing it and its use in therapy. Una forma cristalina de 2,2-difluoro-N-[(1R,2S)-3-metil-1-{[1-(1-m etil-6-oxo-1,6-dihidropiridin-3-il)-1H-indazol-5-iI]oxi}-1-fenilb utan-2-il]propanamida (forma C), composiciones farmacéuticas que la contienen y su uso en terapia.